Lorrain Daniel S.

Chief Scientific OfficerContineum Therapeutics, Inc. (CTNM) · full profile →Form 4 · filed Jul 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$17K
Net Open-Market Flow
-$17K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 9, 2026Option exercise(M)25$1.01$25135K
Jul 9, 2026Sell(S)25$16.00$400135K
Jul 8, 2026Option exercise(M)1K$1.01$1K136K
Jul 8, 2026Sell(S)1K$16.00$16K135K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 9, 2026Option exercise(M)25$033K
Jul 8, 2026Option exercise(M)1K$033K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-047909) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about CTNM insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001628280-26-047909"
Ask your agent
Use Arkolith to summarize insider buying and selling at Contineum Therapeutics, Inc.
over the last 90 days and cite the filings.